Haemodynamic and neuromuscular blocking effects of cisatracurium and pancuronium in patients undergoing coronary artery bypass operations;Cisatracurium bei koronarbypassoperationen - Ein vergleich mit pancuronium: Hämodynamische und neuromuskuläre effekte bei patienten unter chronischer β-blockertherapie

Anaesthesist

Volumn 50, Issue 2, 2001, Pages 87-93

  Rauch, H ^a   Jung, I ^a   Fleischer, F ^a   Bauer, H ^a   Martin, E ^a   Motsch, J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cisatracurium; Haemodynamic effects; Onset time; Pancuronium

Indexed keywords

CISATRACURIUM; ETOMIDATE; MIDAZOLAM; PANCURONIUM; SUFENTANIL;

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; NEUROMUSCULAR BLOCKING; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA; ANIMALS; ATRACURIUM; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HISTAMINE; HUMANS; INTUBATION, INTRATRACHEAL; MALE; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PANCURONIUM; SYNAPTIC TRANSMISSION;

EID: 0035099776     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050969     Document Type: Article

References (22)

1. Evaluation of cisatracurium, a new neuromuscular blocking agent, for tracheal intubation
2. Hypothermic cardiopulmonary bypass and neuromuscular blockade by pancuronium and vecuronium
3. Haemodynamic interactions of muscle relaxants and sufentanil in coronary artery surgery
4. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation
5. Haemodynamic effects of vecuronium, pancuronium and atracurium in patients with coronary artery disease
6. Comparison of haemodynamic effects of metocurine and pancuronium in patients with coronary artery disease
7. Cardiovascular effects of pancuronium in man
8. Importance of the organ-independent elimination of cisatracurium
9. TM) and vecuronium in patients with coronary artery disease
10. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia
11. The cardiovascular effects of vecuronium (org NC 45) and pancuronium in patients undergoing coronary artery bypass grafting
12. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients
13. The effect of different priming doses on the pharmacodynamics of cisatracurium
14. Comparison of the cardiovascular effects of cisatracurium and vecuronium in patients with coronary artery disease
15. Cardiovascular effects of pancuronium and vecuronium during high-dose fentanyl anesthesia
16. Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blockade of cardiac muscarinic receptors
17. A two-center study evaluating the hemodynamic and pharmacodynamic effects of cisatracurium and vecuronium in patients undergoing coronary artery bypass surgery
18. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients
19. Kardiovaskuläre effekte nach bolusapplikation von cisatracurium - Ein vergleich mit vecuronium
20. Cardiovascular effects of pipecuronium and pancuronium in patients undergoing coronary artery bypass grafting
21. Adverse effects of pancuronium during high-dose fentanyl anesthesia for coronary artery bypass grafting
22. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents